Literature DB >> 19853061

Phenotype and functions of spleen dendritic cells in RICK-knockout mice.

Genhong Yao1, Linsong Yang, Yayi Hou.   

Abstract

RICK (receptor-interacting caspase-like apoptosis-regulatory kinase), a protein kinase, promotes nuclear factor kappa B and caspase activation. Herein, in order to further learn the immune role of RICK, its gene in mice was knocked out. Then the phenotype, cytokine, endocytosis and stimulatory capacity of spleen dendritic cells (SDCs) from RICK(-) (knockout) and RICK(+) (wild type) mice were analyzed. Our results showed that the levels of I-Ad, CD11b, CD80 on SDCs from RICK(-) mice were higher while the levels of CD8alpha, CD40, CD45R were lower compared with those from RICK(+) mice; The intracellular levels of IL-4, IL-10, IL-12, IFN-gamma, and TNF-alpha in SDCs from RICK(-) mice were higher than those from RICK(+) mice; The endocytosis and stimulatory capacities of SDCs from RICK(-) mice were higher and lower than those from RICK(+) mice respectively. These data suggested that RICK had a profound influence on the maturation and functions of murine SDCs and subsequently regulated the organ immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19853061     DOI: 10.1016/j.intimp.2009.10.008

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  2 in total

1.  Evaluation of the toxicity of iron-ion irradiation in murine bone marrow dendritic cells via increasing the expression of indoleamine 2,3-dioxygenase 1.

Authors:  Yi Xie; Jun-Fang Yan; Jing-Yi Ma; Hong-Yan Li; Yan-Cheng Ye; Yan-Shan Zhang; Hong Zhang
Journal:  Toxicol Res (Camb)       Date:  2017-09-25       Impact factor: 3.524

2.  Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis.

Authors:  Genhong Yao; Jingjing Qi; Jun Liang; Bingyu Shi; Weiwei Chen; Wenchao Li; Xiaojun Tang; Dandan Wang; Liwei Lu; Wanjun Chen; Songtao Shi; Yayi Hou; Lingyun Sun
Journal:  Theranostics       Date:  2019-10-21       Impact factor: 11.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.